Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients

被引:34
|
作者
Kotikoski, H
Moilanen, E
Vapaatalo, H
Aine, E
机构
[1] Tampere Univ Hosp, Dept Ophthalmol, FIN-33521 Tampere, Finland
[2] Univ Helsinki, Inst Biomed, Helsinki, Finland
[3] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2002年 / 80卷 / 02期
关键词
glaucoma; nitric oxide; aqueous humour; serum; pseudoexfoliation; blood pressure;
D O I
10.1034/j.1600-0420.2002.800214.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study the role of the L-arginine-nitric oxide (NO) pathway in aqueous humour dynamics by measuring nitrate, nitrite and cyclic (cGMP) levels in guanosine 3',5'-monophosphate the aqueous humour of glaucomatous and non-glaucomatous cataract patients. Methods: The study involved 38 glaucoma patients undergoing unilateral cataract surgery in the glaucomatous eye and 38 cataract control patients matched for sex, age, smoking habits and organic nitrate medication. All subjects underwent ophthalmic examination, and blood pressure was measured preoperatively. Nitrite, nitrate and cGMP levels were measured in aqueous humour and serum. Results: The NOx (nitrite + nitrate), nitrite and cGMP concentrations in the aqueous humour were slightly higher in the glaucoma patients than in the control patients, but the differences did not reach statistical significance. The levels of cGMP in serum were higher in the glaucoma patients (P = 0.053). The subgroup of glaucoma patients with pseudoexfoliation had lower NOx and nitrite values in the aqueous humour (P = 0.046 and P = 0.345, respectively) than the matched controls, while cGMP levels were higher (P = 0.043). Levels of NOx and nitrite in the aqueous humour were higher in patients using oral nitroglycerin (P = 0.062 and P = 0.042, respectively) than in patients without this medication. Blood pressure was higher in the glaucoma patients, with a mean of 165/89 mmHg as compared to 153/81 mmHg in the controls (P-values 0.071/0.008). Conclusions: No differences in NO metabolites were found between glaucoma and control patients. However, any real changes may have been disguised by optimal medication of glaucoma. Low NOx and high cGMP levels in the aqueous humour of pseudoexfoliation patients warrant further evaluation in a larger study.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [1] The L-arginine-nitric oxide pathway in hypertension
    Kelm, M
    CURRENT HYPERTENSION REPORTS, 2003, 5 (01) : 80 - 86
  • [2] The L-arginine-nitric oxide pathway in hypertension
    Malte Kelm
    Current Hypertension Reports, 2003, 5 : 80 - 86
  • [3] L-arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients
    Hattenbach, LO
    Allers, A
    Klais, C
    Koch, F
    Hecker, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (01) : 213 - 217
  • [5] L-arginine-nitric oxide pathway in the vascular wall
    Canet, E
    Feletou, M
    Schini, VB
    Vanhoutte, PM
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL I: MOF, MODS AND SIRS - BASIC MECHANISMS IN INFLAMMATION AND TISSUE INJURY, 1996, : 687 - 705
  • [6] The role of l-arginine-nitric oxide pathway in bacterial translocation
    Mirelle Lomar Viana
    Rosana das Graças Carvalho dos Santos
    Simone de Vasconcelos Generoso
    Jacques Robert Nicoli
    Flaviano dos Santos Martins
    José Augusto Nogueira-Machado
    Rosa Maria Esteves Arantes
    Maria Isabel Toulson Davisson Correia
    Valbert Nascimento Cardoso
    Amino Acids, 2013, 45 : 1089 - 1096
  • [7] Impaired L-arginine-nitric oxide pathway in platelets from hypertensive patients
    Moss, M. B.
    Brunini, T. M. C.
    Soares de Moura, R.
    Neto, M. L.
    Novaes-Malagris, L.
    Sabbatini, S.
    Mendes-Ribeiro, A. C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 71 - 71
  • [8] Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
    Ma, Qingyong
    Wang, Zheng
    Zhang, Min
    Hu, Hengtong
    Li, Junhui
    Zhang, Dong
    Guo, Kun
    Sha, Huanchen
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (04) : 392 - 410
  • [9] L-arginine-nitric oxide pathway in a rat model of uraemia
    Brunini, TMC
    Roberts, N
    Yaqoob, M
    Ellory, JC
    Mann, GE
    Ribeiro, ACM
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 506P : 33P - 33P
  • [10] Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients
    Taddei, S
    Virdis, A
    Mattei, P
    Ghiadoni, L
    Sudano, I
    Salvetti, A
    CIRCULATION, 1996, 94 (06) : 1298 - 1303